A5024394794- Cardiac Valve Diseases and Treatments
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Infective Endocarditis Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Heart Failure Treatment and Management
- Peripheral Artery Disease Management
- Cardiac Arrest and Resuscitation
- Retinal Imaging and Analysis
- Venous Thromboembolism Diagnosis and Management
- Mechanical Circulatory Support Devices
- Optical Coherence Tomography Applications
University of Verona
2022-2024
Azienda Ospedaliera Universitaria Integrata Verona
2023-2024
Oxford University Hospitals NHS Trust
2024
BACKGROUND: Patients with ST-segment–elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC). We aim to assess whether nonhyperemic angiography-derived index microcirculatory resistance (NH-IMR angio ) could be a user-friendly tool identify patients ECC, potentially candidates for expedited care pathway and hospital discharge. METHODS: Retrospective analysis 2 independent, international, prospective, observational...
Abstract Background Physiological patterns of coronary artery disease (CAD) have emerged as potential determinants functional results percutaneous interventions (PCI) and vessel-oriented clinical outcomes (VOCE). Objectives In this study, we evaluated the impact angiography-derived physiological CAD on post-PCI long-term outcomes. Methods Pre-PCI fractional flow reserve (FFR) virtual pullbacks were quantitatively interpreted used to determine CAD. Suboptimal physiology was defined an FFR...
Primary percutaneous coronary intervention (pPCI) has revolutionized the prognosis of ST-segment elevation myocardial infarction (STEMI) and is gold standard treatment. As a result its success, number pPCI centres expanded worldwide. Despite decades advancements, clinical outcomes in STEMI patients have plateaued. Out-of-hospital cardiac arrest cardiogenic shock remain major cause high in-hospital mortality, whilst growing burden heart failure long-term survivors presents problem. Many...
Primary percutaneous coronary intervention (pPCI) has revolutionized the prognosis of ST-segment ele-vation myocardial infarction (STEMI) and is gold standard treatment. As a result its success, number pPCI centres expanded worldwide. Despite decades advancements, clinical outcomes in STEMI patients have plateaued. Out-of-hospital car-diac arrest cardiogenic shock remain major cause high in-hospital mortality, whilst growing burden heart failure long-term survivors presents problem. Many...
This study aimed to evaluate the prognostic value of coronary microvascular dysfunction (CMD) at long term after transcatheter aortic valve implantation (TAVI) and explore its relationship with extravalvular cardiac damage (EVCD). Moreover, we sought test correlation between angiography-derived index microcirculatory resistance (IMR
Midterm comparative analyses of the latest iterations most used Evolut and SAPIEN platforms for transcatheter aortic valve implantation (TAVI) are lacking.
Calcific peripheral artery disease (PAD) is a common finding in patients scheduled for transcatheter aortic valve implantation (TAVI) and often requires iliofemoral axis preparation. However, evidence about the use of intravascular lithotripsy (IVL) this setting scarce. The aim study was to describe in-hospital mid-term outcomes IVL-assisted transfemoral (TF)-TAVI with severe calcific PAD.
Download This Paper Open PDF in Browser Add to My Library Share: Permalink Using these links will ensure access this page indefinitely Copy URL DOI
ABSTRACT Background Evidence regarding sex-related differences in response to transcatheter aortic valve implantation according the type is lacking. This study sought evaluate impact of sex on treatment effect Evolut-PRO/PRO+ (PRO) or Sapien 3 Ultra (ULTRA) devices clinical outcomes. Methods Comparative Analysis Evolut PRO vs Valves for Transfemoral Transcatheter Aortic Valve Implantation (OPERA-TAVI) a multicenter multinational registry including patients undergoing latest-iteration ULTRA...
Abstract Background Although in the context of Transcatheter Aortic Valve Implantation (TAVI) technological improvements, refinements technique and increased operator experience have led to progressive reduction most complications, periprocedural neurological ischemic event (stroke TIA) continues occur up 2% patients undergoing TAVI. Many these are attributed embolic events during procedure can lead potentially devastating consequences. Cerebral Embolic Protection (CEP) devices been...